Dr Jonathan Schott

Photo

Personal Profile

Name: Jonathan Schott Email: j.schott@ucl.ac.uk
Title: Dr Tel: 020 3448 3553
Department: Neurodegenerative Diseases Fax:
Position: Senior Clinical Lecturer Address: Institute of Neurology, 8-11 Queen Square, London, WC1N 3BG
Research Domain: Ageing, Biomedical Imaging (Frontier Disciplines), Neuroscience Web Page:  

Profile

Research Description

My research interests are centred on translational research in the dementias, including: the development and application of imaging and cerebrospinal fluid biomarkers in the degenerative dementias for early, specific diagnosis and disease tracking; atypical and young onset dementia; genotype/phenotype correlations in neurodegeneration; clinical trials; autoimmune dementia syndromes; and normal and abnormal ageing. I have several national and international collaborations, including heading an international consortium to determine the genetics of posterior cortical atrophy. I currently supervise 5 PhD students. I have published >75 Medline referenced papers in journals including the Lancet, Lancet Neurology, Annals of Neurology, Archives of Neurology, Brain, and Neurology, and have reviewed papers and grants for numerous journals and grant giving bodies, including the MRC and US NIH. I have authored editorials for journals including Neurology and the BMJ. I have been appointed co-editor (with Prof Masud Husain) of the Oxford Textbook of Cognition and Dementia. I have spoken at numerous national and international conferences, including meetings of the US Alzheimer's Association, European Federation of Neurosciences, Association of British Neurologists and American Academy of Neurology. I am an invited member of the European Federation on Neurological Sciences Dementia Panel, where the focus is on producing evidenced based practice guidelines.


Research Activities

Education Description

 I am involved in teaching at local (undergraduate, MSc, postgraduate), national (including BMJ Neurology Masterclass) and international (including European Federation of Neurological Sciences). I am a member of the Royal College of Physicians Neurology Speciality Certificate Examination standard setting committee.

UCL Collaborators

External Collaborators

Publications

    2013

    • Andreasson U, Lautner R, Schott JM, Mattsson N, Hansson O, Herukka SK, Helisalmi S, Ewers M, Hampel H, Wallin A, Minthon L, Hardy J, Blennow K, Zetterberg H (2013). CSF biomarkers for Alzheimer's pathology and the effect size of APOE ɛ4.. Mol Psychiatry, , - . doi:10.1038/mp.2013.18
    • Barnes J, Carmichael OT, Leung KK, Schwarz C, Ridgway GR, Bartlett JW, Malone IB, Schott JM, Rossor MN, Biessels GJ, Decarli C, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2013). Vascular and Alzheimer's disease markers independently predict brain atrophy rate in Alzheimer's Disease Neuroimaging Initiative controls.. Neurobiol Aging, 34(8), 1996 - 2002. doi:10.1016/j.neurobiolaging.2013.02.003
    • Andrews KA, Modat M, Macdonald KE, Yeatman T, Cardoso MJ, Leung KK, Barnes J, Villemagne VL, Rowe CC, Fox NC, Ourselin S, Schott JM, the Australian Imaging Biomarkers , Lifestyle Flagship Study of Ageing (2013). Atrophy Rates in Asymptomatic Amyloidosis: Implications for Alzheimer Prevention Trials. PLoS ONE, 8(3), e58816 - . doi:10.1371/journal.pone.0058816
    • Mahoney CJ, Malone IB, Ridgway GR, Buckley AH, Downey LE, Golden HL, Ryan NS, Ourselin S, Schott JM, Rossor MN, Fox NC, Warren JD (2013). White matter tract signatures of the progressive aphasias. Neurobiology of Aging, 34(6), 1687 - 1699.
    • Fletcher PD, Downey LE, Agustus JL, Hailstone JC, Tyndall MH, Cifelli A, Schott JM, Warrington EK, Warren JD (2013). Agnosia for accents in primary progressive aphasia.. Neuropsychologia, , - . doi:10.1016/j.neuropsychologia.2013.05.013
    • Pertzov Y, Miller TD, Gorgoraptis N, Caine D, Schott JM, Butler C, Husain M (2013). Binding deficits in memory following medial temporal lobe damage in patients with voltage-gated potassium channel complex antibody-associated limbic encephalitis.. Brain, , - . doi:10.1093/brain/awt129
    • Magdalinou NK, Ling H, Smith JDS, Schott JM, Watkins LD, Lees AJ (2013). Normal pressure hydrocephalus or progressive supranuclear palsy? A clinicopathological case series. Journal of Neurology, 260(4), 1009 - 1013.
    • Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S (2013). Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population. American Journal of Human Genetics, 92(3), 345 - 353.
    • Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC, Alzheimer's Disease Neuroimaging Initiative (2013). Visual ratings of atrophy in MCI: prediction of conversion and relationship with CSF biomarkers.. Neurobiol Aging, 34(1), 73 - 82. doi:10.1016/j.neurobiolaging.2012.03.010
    • Beck J, Poulter M, Hensman D, Rohrer JD, Mahoney CJ, Adamson G, Campbell T, Uphill J, Borg A, Fratta P, Orrell RW, Malaspina A, Rowe J, Brown J, Hodges J, Sidle K, Polke JM, Houlden H, Schott JM, Fox NC, Rossor MN, Tabrizi SJ, Isaacs AM, Hardy J, Warren JD, Collinge J, Mead S (2013). Large C9orf72 hexanucleotide repeat expansions are seen in multiple neurodegenerative syndromes and are more frequent than expected in the UK population.. Am J Hum Genet, 92(3), 345 - 353. doi:10.1016/j.ajhg.2013.01.011
    • Liang Y, Ryan NS, Schott JM, Fox NC (2013). Imaging the onset and progression of Alzheimer's disease: Implications for prevention trials. Journal of Alzheimer's Disease, 33(SUPPL. 1), S305 - S312.
    • Barnes J, Bartlett JW, Fox NC, Schott JM (2013). Targeted recruitment using cerebrospinal fluid biomarkers: implications for Alzheimer's disease therapeutic trials.. J Alzheimers Dis, 34(2), 431 - 437. doi:10.3233/JAD-121936
    • Liang Y, Ryan NS, Schott JM, Fox NC (2013). Imaging the onset and progression of Alzheimer's disease: implications for prevention trials.. J Alzheimers Dis, 33 Suppl 1, S305 - S312. doi:10.3233/JAD-2012-129010
    • Malone IB, Cash D, Ridgway GR, MacManus DG, Ourselin S, Fox NC, Schott JM (2013). MIRIAD--Public release of a multiple time point Alzheimer's MR imaging dataset.. Neuroimage, 70, 33 - 36. doi:10.1016/j.neuroimage.2012.12.044
    • Lehmann M, Koedam EL, Barnes J, Bartlett JW, Barkhof F, Wattjes MP, Schott JM, Scheltens P, Fox NC (2013). Visual ratings of atrophy in MCI: Prediction of conversion and relationship with CSF biomarkers. Neurobiology of Aging, 34(1), 73 - 82.

    2012

    • Schott JM, IEEE (2012). MRI BIOMARKERS IN NEURODEGENERATIVE DISORDERS.
    • Schott JM (2012). Voltage gated potassium channel complex antibody associated limbic encephalitis.
    • Schott JM, Bartlett JW (2012). Investigating missing data in Alzheimer disease studies.. Neurology, 78(18), 1370 - 1371. doi:10.1212/WNL.0b013e318253d66b
    • Ryan NS, Bastos-Leite AJ, Rohrer JD, Werring DJ, Fox NC, Rossor MN, Schott JM (2012). Cerebral microbleeds in familial Alzheimer's disease. Brain, 135(1), - .
    • Schrag A, Schott JM (2012). Images in clinical medicine. Kayser-Fleischer rings in Wilson's disease.. N Engl J Med, 366(12), e18 - . doi:10.1056/NEJMicm1101534
    • Ryan N, Biessels G, Bastos-Leite A, Beck J, Mead S, Morris H, Schott JM, Rossor MN, Fox NC (2012). WHITE MATTER LESIONS IN FAMILIAL ALZHEIMER'S DISEASE: EVIDENCE FOR INFLUENCE OF MUTATION POSITION ON AMYLOID ANGIOPATHY?. doi:10.1136/jnnp-2011-301993.1
    • Crutch SJ, Lehmann M, Schott JM, Rabinovici GD, Rossor MN, Fox NC (2012). Posterior cortical atrophy.. Lancet Neurol, 11(2), 170 - 178. doi:10.1016/S1474-4422(11)70289-7
    • Bartlett JW, Frost C, Mattsson N, Skillbäck T, Blennow K, Zetterberg H, Schott JM (2012). Determining cut-points for Alzheimers disease biomarkers: Statistical issues, methods and challenges. Biomarkers in Medicine, 6(4), 391 - 400.
    • Schott JM (2012). Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging, 33(7), 1486.e9 - 1486.e15.
    • Magdalinou NK, Ling H, Schott JM, Lees AJ (2012). Normal pressure hydorcephalus or progressive supranuclear palsy? A clinicopathological case series.
    • Schrag A, Schott JM, Alzheimer's Disease Neuroimaging Initiative (2012). What is the clinically relevant change on the ADAS-Cog?. J Neurol Neurosurg Psychiatry, 83(2), 171 - 173. doi:10.1136/jnnp-2011-300881
    • Crutch SJ, Schott JM, Rabinovici GD, Boeve BF, Cappa SF, Dickerson BC, Dubois B, Graff-Radford NR, Krolak-Salmon P, Lehmann M, Mendez MF, Pijnenburg Y, Ryan NS, Scheltens P, Shakespeare T, Tang-Wai DF, van der Flier WM, Bain L, Carrillo MC, Fox NC (2012). Shining a light on posterior cortical atrophy.. Alzheimers Dement, , - . doi:10.1016/j.jalz.2012.11.004
    • Warren J, Rohrer JD, Lashley T, Schott JM, Beck J, Mead S, Fox NC, Revesz T, Hardy J, Rossor MN (2012). The frontotemporal lobar degenerations as 'molecular nexopathies'.
    • Schott JM, Warren JD (2012). Alzheimer's disease: mimics and chameleons.. Pract Neurol, 12(6), 358 - 366. doi:10.1136/practneurol-2012-000315
    • Mahoney CJ, Beck J, Rohrer JD, Lashley T, Mok K, Shakespeare T, Yeatman T, Warrington EK, Schott JM, Fox NC, Rossor MN, Hardy J, Collinge J, Revesz T, Mead S, Warren JD (2012). Frontotemporal dementia with the C9ORF72 hexanucleotide repeat expansion: clinical, neuroanatomical and neuropathological features.. Brain, 135(Pt 3), 736 - 750. doi:10.1093/brain/awr361

    2011

    • Irani SR, Vincent A, Schott JM (2011). Autoimmune encephalitis.. BMJ, 342, d1918 - .
    • Irani SR, Vincent A, Schott JM (2011). Autoimmune encephalitis. BRIT MED J, 342, - . doi:10.1136/bmj.d1918
    • Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJE, Zagami AS, Bleasel A, Somerville ER, Smith SMJ, Vincent A (2011). Faciobrachial Dystonic Seizures Precede Lgi1 Antibody Limbic Encephalitis. ANN NEUROL, 69(5), 892 - 900. doi:10.1002/ana.22307
    • Irani SR, Michell AW, Johnson MR, Schott JM, Somerville ER, Vincent A, Smith SMJ (2011). Faciobrachial Dystonic Attacks: Seizures or Movement Disorder? Reply. ANN NEUROL, 70(1), 180 - 180. doi:10.1002/ana.22471
    • Irani SR, Schott JM, Vincent A, Smith SJ (2011). Tonic seizures: a diagnostic clue of anti-LGI1 encephalitis?. Neurology, 77(24), 2140 - 2141.
    • Schott JM (2011). Using CSF biomarkers to replicate genetic associations in Alzheimer's disease. Neurobiology of Aging, , - .
    • Rohrer JD, Schott JM (2011). Primary progressive aphasia-defining genetic and pathological subtypes. Current Alzheimer Research, 8(3), 266 - 272.
    • Anderson V, Schott J, Bartlett J, Leung KK, Miller DH, Fox NC (2011). Grey matter atrophy rate as a marker of disease progression in AD. Neurobiology of Aging, , - . doi:10.1016/j.neurobiolaging.2010.11.001
    • Irani SR, Michell AW, Lang B, Pettingill P, Waters P, Johnson MR, Schott JM, Armstrong RJE, S Zagami A, Bleasel A, Somerville ER, Smith SMJ, Vincent A (2011). Faciobrachial dystonic seizures precede Lgi1 antibody limbic encephalitis. Annals of Neurology, 69(5), 892 - 900.
    • Rohrer JD, Lashley T, Schott JM, Warren JE, Mead S, Isaacs AM, Beck J, Hardy J, de Silva R, Warrington E, Troakes C, Al-Sarraj S, King A, Borroni B, Clarkson M, Ourselin S, Holton J, Fox NC, Revesz T, Rossor MN, Warren JD (2011). Clinical and neuroanatomical signatures of tissue pathology in frontotemporal lobar degeneration. Brain, 134(9), 2565 - 2581.
    • Revesz T, Schott JM, Reiniger L, Thom M, Holton JL, Grieve J, Brandner S, Warren JD (2011). Brain biopsy in dementia: clinical indications and neuropathological diagnostic approach.
    • Fox NC, Ridgway GR, Schott JM (2011). Algorithms, atrophy and Alzheimer's disease: cautionary tales for clinical trials.. Neuroimage, 57(1), 15 - 18. doi:10.1016/j.neuroimage.2011.01.077
    • Schott JM, Warren JD, Rossor MN, Revesz T (2011). Open biopsy in patients with acute progressive neurologic decline and absence of mass lesion.. Neurology, 76(21), 1847 - . doi:10.1212/WNL.0b013e318210e621
    • Schott JM, Warren JD, Barkhof F, Rossor MN, Fox NC (2011). Suspected early dementia. BMJ (Online), 343(7824), - .
    • Schott JM (2011). Spectra to identify the spectre of Alzheimer disease?. Neurology, 77(10), 932 - 933. doi:10.1212/WNL.0b013e31822cfce6
    • Schott JM, Warren JD, Barkhof F, Rossor MN, Fox NC (2011). RATIONAL IMAGING Suspected early dementia. BRIT MED J, 343, - . doi:10.1136/bmj.d5568
    • Irani SR, Michell AW, Johnson MR, Schott JM, Somerville ER, Vincent A, Smith SM (2011). Reply.. Ann Neurol, 70(1), 180 - . doi:10.1002/ana.22471

    2010

    • Schott JM, Bartlett JW, Fox NC, Barnes J (2010). Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42. Annals of Neurology, 68(6), 825 - 834.
    • Revesz T, Schott JM, Holton JL, Reiniger L, Brandner S, Thom M, Warren JD (2010). Brain biopsy in dementia - clinical indications and diagnostic approach.
    • Schott JM, Reiniger L, Thom M, Holton JL, Grieve J, Brandner S, Warren JD, Revesz T (2010). Brain biopsy in dementia: clinical indications and diagnostic approach.. Acta Neuropathol, 120(3), 327 - 341. doi:10.1007/s00401-010-0721-y
    • Schott JM, Frost C, MacManus DG, Ibrahim F, Waldman AD, Fox NC (2010). Short echo time proton magnetic resonance spectroscopy in Alzheimer's disease: a longitudinal multiple time point study.. Brain, 133(11), 3315 - 3322. doi:10.1093/brain/awq208
    • Schott JM, Bartlett JW, Barnes J, Leung KK, Ourselin S, Fox NC (2010). Reduced sample sizes for atrophy outcomes in Alzheimer's disease trials: baseline adjustment. Neurobiol Aging, 31(8), 1452 - 1462.e2.
    • Rossor MN, Fox NC, Mummery CJ, Schott JM, Warren JD (2010). The diagnosis of young-onset dementia.. Lancet Neurol, 9(8), 793 - 806. doi:10.1016/S1474-4422(10)70159-9
    • Guerreiro RJ, Beck J, Gibbs JR, Santana I, Rossor MN, Schott JM, Nalls MA, Ribeiro H, Santiago B, Fox NC, Oliveira C, Collinge J, Mead S, Singleton A, Hardy J (2010). Genetic variability in CLU and its association with Alzheimer's disease.. PLoS One, 5(3), e9510 - . doi:10.1371/journal.pone.0009510
    • Anderson VM, Schott JM, Bartlett JW, Leung KK, Miller DH, Fox NC (2010). Gray matter atrophy rate as a marker of disease progression in AD. Neurobiology of Aging, , - .
    • Schott JM, Bartlett JW, Fox NC, Barnes J, Alzheimer's Disease Neuroimaging Initiative Investigators (2010). Increased brain atrophy rates in cognitively normal older adults with low cerebrospinal fluid Aβ1-42.. Ann Neurol, 68(6), 825 - 834. doi:10.1002/ana.22315
    • Tolboom N, Koedam EL, Schott JM, Yaqub M, Blankenstein MA, Barkhof F, Pijnenburg YA, Lammertsma AA, Scheltens P, van Berckel BN (2010). Dementia mimicking Alzheimer's disease Owing to a tau mutation: CSF and PET findings.. Alzheimer Dis Assoc Disord, 24(3), 303 - 307. doi:10.1097/WAD.0b013e3181cf35ec

    2009

    • Gutiérrez-Galve L, Lehmann M, Hobbs NZ, Clarkson MJ, Ridgway GR, Crutch S, Ourselin S, Schott JM, Fox NC, Barnes J (2009). Patterns of cortical thickness according to APOE genotype in Alzheimer's disease.. Dement Geriatr Cogn Disord, 28(5), 476 - 485. doi:10.1159/000258100

    2008

    • Schott JM, Crutch SJ, Frost C, Warrington EK, Rossor MN, Fox NC (2008). Neuropsychological correlates of whole brain atrophy in Alzheimer's disease. Neuropsychologia, 46(6), 1732 - 1737. doi:10.1016/j.neuropsychologia.2008.02.015
    • Barnes J, Foster J, Boyes RG, Pepple T, Moore EK, Schott JM, Frost C, Scahill RI, Fox NC (2008). A comparison of methods for the automated calculation of volumes and atrophy rates in the hippocampus. NeuroImage, 40(4), 1655 - 1671. doi:10.1016/j.neuroimage.2008.01.012
    • Barnes J, Scahill RI, Frost C, Schott JM, Rossor MN, Fox NC (2008). Increased hippocampal atrophy rates in AD over 6 months using serial MR imaging. NEUROBIOL AGING, 29(8), 1199 - 1203. doi:10.1016/j.neurobiolaging.2007.02.01
    • Gallagher DA, Schott JM, Childerhouse A, Wilhelm T, Gale AN, Schrag A (2008). Reversible "Applause sign" secondary to diffuse large B cell lymphoma. Movement Disorders, 23(16), 2426 - 2428. doi:10.1002/mds.22311
    • Schott JM (2008). Ischemic bilateral hippocampal dysfunction during transient global amnesia.. Neurology, 70(20), 1940 - . doi:10.1212/01.wnl.0000314641.73292.d3

    2007

    • Smith SM, Rao A, De Stefano N, Jenkinson M, Schott JM, Matthews PM, Fox NC (2007). Longitudinal and cross-sectional analysis of atrophy in Alzheimer's disease: Cross-validation of BSI, SIENA and SIENAX. NeuroImage, 36(4), 1200 - 1206. doi:10.1016/j.neuroimage.2007.04.035
    • Ridha BH, Barnes J, van de Pol LA, Schott JM, Boyes RG, Siddique MM, Rossor MN, Scheltens P, Fox NC (2007). Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Archives of Neurology, 64(6), 849 - 854. doi:10.1001/archneur.64.6.849
    • Barnes J, Lewis EB, Scahill RI, Bartlett JW, Frost C, Schott JM, Rossor MN, Fox NC (2007). Automated measurement of hippocampal atrophy using fluid-registered serial MRI in AD and controls. Journal of Computer Assisted Tomography, 31(4), 581 - 587.
    • Schott JM, Williams DR, Butterworth RJ, Janssen JC, Larner AJ, Holton JL, Rossor MN (2007). Shunt responsive progressive supranuclear palsy?. Movement Disorders, 22(6), 902 - 903. doi:10.1002/mds.21404
    • Schott JM, Warren JD (2007). Steroid responsive encephalopathy with positive thyroid antibodies. A syndrome, not a diagnosis?. Journal of Neurology, 254(4), 542 - . doi:10.1007/s00415-006-0279-8
    • Barnes J, Boyes RG, Lewis EB, Schott JM, Frost C, Scahill RI, Fox NC (2007). Automatic calculation of hippocampal atrophy rates using a hippocampal template and boundary shift integral.. Neurobiology of Aging, 28(11), 1657 - 1663. doi:10.1016/j.neurobiolaging.2006.07.008
    • Schott JM (2007). A neurological MRI menagerie. Practical Neurology, 7(3), 186 - 190. doi:10.1136/jnnp.2007.120261

    2006

    • Schrag A, Schott JM (2006). Epidemiological, clinical, and genetic characteristics of early-onset parkinsonism. The Lancet Neurology, 5(4), 355 - 363.
    • Schott JM (2006). Another case of voltage-gated potassium channel antibody-related encephalopathy?. European Neurology, 55(2), 110 - 110. doi:10.1159/000092787
    • Schott JM (2006). Limbic encephalitis: a clinician's guide. Practical Neurology, 6, 143 - 153.
    • Schott JM, Kennedy J, Fox NC (2006). New developments in mild cognitive impairment and Alzheimer's disease. Current Opinion in Neurology, 19(6), 552 - 558.
    • Garrard P, Schott JM, MacManus DG, Hodges JR, Fox NC, Waldman AD (2006). Posterior cingulate neurometabolite profiles and clinical phenotype in frontotemporal dementia.. Cogn Behav Neurol, 19(4), 185 - 189. doi:10.1097/01.wnn.0000213915.72395.77
    • Schott JM, Frost C, Whitwell JL, MacManus DG, Boyes RG, Rossor MN, Fox NC (2006). Combining short interval MRI in Alzheimer's disease : Implications for therapeutic trials. Journal of Neurology, 253(9), 1147 - 1153.
    • Boyes RG, Rueckert D, Aljabar P, Whitwell J, Schott JM, Hill DL, Fox NC (2006). Cerebral atrophy measurements using Jacobian integration: Comparison with the boundary shift integral. NeuroImage, 32(1), 159 - 169.
    • Godbolt AK, Waldman AD, MacManus DG, Schott JM, Frost C, Cipolotti L, Fox NC, Rossor MN (2006). MRS shows abnormalities before symptoms in familial Alzheimer disease. Neurology, 66(5), 718 - 722.
    • Schott JM, Ridha BH, Crutch SJ, Healy DG, Uphill JB, Warrington EK, Rossor MN, Fox NC (2006). Apolipoprotein E genotype modifies the phenotype of Alzheimer disease. Archives of Neurology, 63(1), 155 - 156.

    2005

    • Warren JD, Schott JM, Fox NC, Thom M, Revesz T, Holton JL, Scaravilli F, Thomas DG, Plant GT, Rudge P, Rossor MN (2005). Brain biopsy in dementia. Brain, 128(9), 2016 - 2025. doi:10.1093/brain/awh543
    • Schott JM, Price SL, Frost C, Whitwell JL, Rossor MN, Fox NC (2005). Measuring atrophy in Alzheimer disease: a serial MRI study over 6 and 12 months. Neurology, 65(1), 119 - 124.
    • Schott JM, Warren JD, Fox NC, Thom M, Revesz T, Scaravilli F, Holton J, Thomas DGT, Plant GT, Rudge P, Rossor MN (2005). Brain biopsy in dementia: A review of 90 consecutive cases from Queen Square.
    • Ridha BH, Schott JM, Crutch SJ, Healy DG, Uphill JB, Warrington EW, Rossor MN, Fox NC (2005). Apoliprotein E genotype modifies the phenotype of Alzheimer's disease.
    • Janssen JC, Schott JM, Cipolotti L, Fox NC, Scahill RI, Josephs KA, Stevens JM, Rossor MN (2005). Mapping the onset and progression of atrophy in familial frontotemporal lobar degeneration. Journal of Neurology, Neurosurgery and Psychiatry, 76(2), 162 - 168.
    • Barnes J, Scahill RI, Schott JM, Frost C, Rossor MN, Fox NC (2005). Does Alzheimer's disease affect hippocampal asymmetry? Evidence from a cross-sectional and longitudinal volumetric MRI study. Dementia and Geriatric Cognitive Disorders, 19(5-6), 338 - 344.
    • Schott GD, Schott JM (2005). Etiology of mirror writing in Japanese - In reply. Archives of Neurology, 62(5), 835 - 835.
    • Archer HA, Schott JM, Barnes J, Fox NC, Holton JL, Revesz T, Cipolotti L, Rossor MN (2005). Knight's move thinking? Mild cognitive impairment in a chess player. Neurocase, 11(1), 26 - 31.

    2004

    • Fox NC, Schott JM, Scahill RI (2004). Measuring progression in Alzheimer's disease using serial MRI: 4D MRI. In Hyman B, Demonet JF, Christen Y (Ed.), The Living Brain and Alzheimer's Disease (pp. 61 - 74). : Springer-Verlag.
    • Boyes RG, Schott JM, Frost C, Fox NC (2004). Increasing accuracy of atrophy measures from serial MR scans using parameter analysis of the boundary shift integral. Lecture Notes In Computer Science, 3217, 1036 - 1037.
    • Fox NCI, Schott JM (2004). Imaging cerebral atrophy: normal ageing to Alzheimer's disease. The Lancet, 363(9406), 392 - 394. doi:10.1016/S0140-6736(04)15441-X
    • Scahill RI, Schott JM, Stevens JM, Janssen JC, Rossor MN, Fox NC (2004). Fluid registration of serial MRI: Identifying regional changes in Alzheimer's disease.
    • Schott JM, Fox NC, Frost C, Scahill RI, Chan D, Janssen JC, Jenkins R, Rossor MN (2004). Familial Alzheimer's disease: How early does medial temporal lobe atrophy occur?.
    • Fox N, Schott J, Barnes J, Price S, Anderson V, Whitwell J, Rossor M (2004). MRI to measure progression to AD and in AD.
    • Schott JM, Janssen JC, Cipolotti L, Fox NC, Scahill RI, Josephs KA, Stevens JM, Rossor MN (2004). Presymptomatic focal atrophy precedes speech production impairment in familial frontotemporal lobar degeneration.
    • Fox NC, Schott JM, Frost C, Rossor MN (2004). Serial magnetic resonance imaging as an outcome measure in dementia.
    • Whitwell JL, Schott JM, Lewis EB, MacManus DG, Fox NC (2004). Using nine degrees-of-freedom registration to correct for changes in voxel size in serial MRI studies. Magnetic Resonance Imaging, 22(7), 993 - 999.
    • Paviour DC, Schott JM, Stevens JM, Revesz T, Holton JL, Rossor MN, Lees AJ, Fox NC (2004). Pathological substrate for regional distribution of increased atrophy rates in progressive supranuclear palsy. Journal of Neurology, Neurosurgery and Psychiatry, 75(12), 1772 - 1775.
    • Schott GD, Schott JM (2004). Mirror writing, left-handedness, and leftward scripts. Archives of Neurology, 61(12), 1849 - 1851.
    • Chan D, Walters RJ, Sampson EL, Schott JM, Smith SJ, Rossor MN (2004). EEG abnormalities in frontotemporal lobar degeneration. Neurology, 62(9), 1628 - 1630.
    • Schott JM, Fox NC (2004). Structural imaging in the dementias. Psychiatry, 3(12), 22 - 26.
    • Vincent A, Buckley C, Schott JM, Baker I, Dewar BK, Detert N, Clover L, Parkinson A, Bien CG, Omer S, Lang B, Rossor MN, Palace J (2004). Potassium channel antibody-associated encephalopathy: a potentially immunotherapy-responsive form of limbic encephalitis. Brain, 127(3), 701 - 712.
    • Schott JM, Frost C, Crutch SJ, Boyes RG, Whitwell JL, Scahill RI, Rossor MN, Warrington EK, Fox NC (2004). Predictors and correlates of inter-individual variation in MRI derived atrophy rates in Alzheimer's disease.
    • Schott JM, Lees AJ, Rossor MN (2004). Dementia in dementia with Lewy bodies may not be attributable to Alzheimer pathology. Annals of Neurology, 56(4), 604 - 604. doi:10.1002/ana.20271
    • Mahapatra RK, Edwards MJ, Schott JM, Bhatia KP (2004). Corticobasal degeneration. The Lancet Neurology, 3(12), 736 - 743.
    • Schott JM, Vincent A, Clover L, Buckley C, Gabel A, Lang B, Omer S, Bien CG, Palace J, Rossor MN (2004). Potassium channel antibody associated encephalitis: A potentially treatable non-paraneoplastic limbic encephalitis.

    2003

    • Schott JM, Simon JE, Fox NC, King AP, Khan MN, Cipolotti L, Paviour DC, Stevens JM, Rossor MN (2003). Delineating the sites and progression of in vivo atrophy in multiple system atrophy using fluid-registered MRI. Movement Disorders, 18(8), 955 - 958.
    • Schott JM, Crutch SJ, Fox NC, Warrington EK (2003). Development of selective verbal memory impairment secondary to a left thalamic infarct: a longitudinal case study. Journal of Neurology, Neurosurgery and Psychiatry, 74(2), 255 - 257.
    • Walters RJL, Fox NC, Schott JM, Crum WR, Stevens JM, Rossor MN, Thomas DJ (2003). Transient ischaemic attacks are associated with increased rates of global cerebral atrophy. Journal of Neurology, Neurosurgery and Psychiatry, 74(2), 213 - 216.
    • Schott JM, Fox NC, Frost C, Scahill RI, Janssen JC, Chan D, Jenkins R, Rossor MN (2003). Assessing the onset of structural change in familial Alzheimer's disease. Annals of Neurology, 53(2), 181 - 188. doi:10.1002/ana.10424
    • Schott JM, Harkness K, Barnes J, Della Rocchetta AI, Vincent A, Rossor MN (2003). Amnesia, cerebral atrophy, and autoimmunity. The Lancet, 361(9365), 1266 - 1266. doi:10.1016/S0140-6736(03)12983-2
    • Schott JM, Warren JD, Rossor MN (2003). The uncertain nosology of Hashimoto encephalopathy.. Arch Neurol, 60(12), 1812 - . doi:10.1001/archneur.60.12.1812-a
    • Schott JM, Rossor MN (2003). The grasp and other primitive reflexes. Journal of Neurology, Neurosurgery and Psychiatry, 74(5), 558 - 560.

    2002

    • Schott JM, Fox NC, Rossor MN (2002). Genetics of the dementias.. J Neurol Neurosurg Psychiatry, 73 Suppl 2, II27 - II31.
    • Janssen JC, Scahill RI, Schott JM, Whitwell J, Warrington E, Rossor MN, Fox NC, Stevens JM, Cipolotti L (2002). In vivo mapping of the onset and progression of neurodegeneration in frontotemporal lobar degeneration. NEUROBIOL AGING, 23(1), S479 - S479.
    • Scahill RI, Schott JM, Stevens JM, Rossor MN, Fox NC (2002). Mapping the evolution of regional atrophy in Alzheimer's disease: unbiased analysis of fluid-registered serial MRI. Proceedings of the National Academy of Sciences of the United States of America, 99(7), 4703 - 4707. doi:10.1073/pnas.052587399

    2000

    • Rigby SP, Schott JM, Bliss P, Higgens CS, Kamm MA (2000). Dilated stomach and weak muscles. Lancet, 356(9245), 1898 - 1898.

    1999

    • Schott JM, Rigby SP, McNally JD, Keat A, Higgens CS (1999). Oral methotrexate: the hazard of different tablet strengths.. Rheumatology (Oxford), 38(4), 382 - .

    1995

    • Rutherford OM, Beshyah SA, Schott J, Watkins Y, Johnston DG (1995). Contractile properties of the quadriceps muscle in growth hormone-deficient hypopituitary adults.. Clin Sci (Lond), 88(1), 67 - 71.
    • Schott J, Puttick M (1995). Handedness among surgeons.. BMJ, 310(6981), 739 - .
    • Schott J, McCully K, Rutherford OM (1995). The role of metabolites in strength training. II. Short versus long isometric contractions.. Eur J Appl Physiol Occup Physiol, 71(4), 337 - 341.

    1994

    • SCHOTT J, RUTHERFORD O (1994). CHANGES IN FATIGUABILITY AND CONTRACTILE PROPERTIES OF THE HUMAN QUADRICEPS FOLLOWING ISOMETRIC STRENGTH TRAINING. JOURNAL OF PHYSIOLOGY-LONDON, 475P, P26 - P27.

    • Scahill RI, Ridgway GR, Barnes J, Ryan NS, Clarkson MJ, Foster J, Crutch SJ, Schott JM, Ourselin S, Warren JD, Hardy J, Rossor MN, Fox NC (). Genetic influences on atrophy patterns in familial AD: a comparason of APP and PSEN-1 mutations. Journal of AD, , - .